Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992
- PMID: 7548596
- DOI: 10.1093/clinids/20.supplement_2.s352
Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992
Abstract
The antimicrobial susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron collected from December 1990 through November 1992 was determined by the agar dilution technique. Metronidazole, imipenem, and cefoperazone/sulbactam remained highly active against both organisms. Rates of resistance to those agents were 0, 2%, and 0.9% in B. fragilis and 0, 0.9%, and 3% in B. thetaiotaomicron, respectively. Cefoxitin and other cephamycins were active against B. fragilis; rates of resistance to these agents did not tend to increase. With the inclusion of these data, the variation of rates of resistance to several agents was summarized for each year from 1987 to 1992. Rates of resistance to imipenem decreased in 1991 and 1992 among isolates of B. fragilis (2.3% in 1991, 1.8% in 1992) and B. thetaiotaomicron (2.4% in 1991, 0 in 1992). Rates of resistance to cefoxitin in B. thetaiotaomicron varied from 10% to 38% during these 6 years, though the distributional peak of MIC values did not change. The rate of resistance to ofloxacin in B. fragilis increased from 42% in 1989 to 81% in 1992. The rate of resistance to ampicillin in B. thetaiotaomicron was 68% in 1992--approximately 30% lower than before. Mostly, however, the rates of resistance to the antimicrobial agents examined did not change significantly.
Similar articles
-
In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1069-73. doi: 10.1007/BF01967801. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1295761
-
Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.Clin Infect Dis. 1993 Jun;16 Suppl 4:S382-6. doi: 10.1093/clinids/16.supplement_4.s382. Clin Infect Dis. 1993. PMID: 8324152
-
Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.Korean J Lab Med. 2009 Aug;29(4):293-8. doi: 10.3343/kjlm.2009.29.4.293. Korean J Lab Med. 2009. PMID: 19726890
-
Epidemiology and antimicrobial resistance of B. fragilis group organisms isolated from clinical specimen and human intestinal microbiota.Rev Inst Med Trop Sao Paulo. 1996 Sep-Oct;38(5):329-35. doi: 10.1590/s0036-46651996000500003. Rev Inst Med Trop Sao Paulo. 1996. PMID: 9293074 Review.
-
Newer beta-lactam agents and the Bacteroides fragilis group.Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S. Pharmacotherapy. 1991. PMID: 2041832 Review.
Cited by
-
New insertion sequence elements in the upstream region of cfiA in imipenem-resistant Bacteroides fragilis strains.Antimicrob Agents Chemother. 2003 Mar;47(3):979-85. doi: 10.1128/AAC.47.3.979-985.2003. Antimicrob Agents Chemother. 2003. PMID: 12604530 Free PMC article.
-
Identification of Bacteroides thetaiotaomicron on the basis of an unexpected specific amplicon of universal 16S ribosomal DNA PCR.J Clin Microbiol. 2004 Apr;42(4):1727-30. doi: 10.1128/JCM.42.4.1727-1730.2004. J Clin Microbiol. 2004. PMID: 15071033 Free PMC article.
-
PCR assay for species-specific identification of Bacteroides thetaiotaomicron.J Clin Microbiol. 2000 Apr;38(4):1672-5. doi: 10.1128/JCM.38.4.1672-1675.2000. J Clin Microbiol. 2000. PMID: 10747167 Free PMC article.
-
High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.Antimicrob Agents Chemother. 2002 Sep;46(9):2908-13. doi: 10.1128/AAC.46.9.2908-2913.2002. Antimicrob Agents Chemother. 2002. PMID: 12183246 Free PMC article.
-
In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone.Antimicrob Agents Chemother. 2006 Nov;50(11):3908-13. doi: 10.1128/AAC.00639-06. Antimicrob Agents Chemother. 2006. PMID: 17065629 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical